Loading data for ACON — first visit, this takes a few seconds.
Aclarion Inc. (ACON)
NasdaqCM: ACON
· Real-Time Price · USD
2.71
+0.02 (0.74%)
At close: Aug 21, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Aclarion Inc. (ACON) Stock Price, Analysis & Data
0.74% (1D)
No data available
| Bid | 1.94 |
| Market Cap | 7.81M |
| Revenue (ttm) | 83.77K |
| Net Income (ttm) | -9.2M |
| 1.22 | |
| -6.96 | |
| n/a | |
| -0.5 | |
| P/B (ttm) | 0.39 |
| P/S (ttm) | 93.25 |
| Earnings Date | n/a |
| Ask | 3.34 |
| Volume | 44,236 |
| Avg. Volume (20D) | 73,879 |
| Open | 2.75 |
| Previous Close | 2.69 |
| Day's Range | 2.58 - 2.83 |
| 52-Week Range | 1.95 - 12.03 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About ACON
Aclarion, Inc. operates as a healthcare technology company in the United States. It uses magnetic resonance spectroscopy (MRS) combined with proprietary signal-processing biomarkers to optimize clinical treatments. The company develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. It also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercial...
Industry Health Information Services
Sector Healthcare
IPO Date Apr 22, 2022
Employees 10
Stock Exchange NasdaqCM
Ticker Symbol ACON
Website https://www.aclarion.com
Financial Performance
In 2025, Aclarion's revenue was 75.73K, an increase of 65.62% compared to the previous year's 45.72K. Earnings were -7.23M, an increase of 3.44%.
Financial StatementsEarnings Surprise
Aclarion has released their quarterly earnings on Aug 6, 2026:
- Revenue of $25.21K misses estimates by $0, with 30.48% YoY growth.
- EPS of -1.12 misses estimates by -0.07, with 59.27% YoY growth.
